Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

Silvia Stringhini; Ania Wisniak; Giovanni Piumatti; Andrew S. Azman; Stephen A. Lauer; Hélène Baysson; David De Ridder; Dušan Petrović; Stephanie Schrempft; Kailing Marcus; Sabine Yerly; Isabelle Arm Vernez; Olivia Keiser; Samia Hurst; Klara M. Posfay‐Barbe; Didier Trono; Didier Pittet; Laurent Gétaz; François Chappuis; Isabella Eckerle; Nicolas Vuilleumier; Benjamin Meyer; Antoine Flahault; Laurent Kaiser; Idris Guessous

doi:10.1016/s0140-6736(20)31304-0

Keywords

SeroprevalenceMedicinePopulationDemographyLogistic regressionAntibodyImmunologyInternal medicineEnvironmental healthSerology

Affiliated Institutions

Related Publications

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Juanjuan Zhao , Quan Yuan , Haiyan Wang +22 more

Abstract Background The novel coronavirus SARS-CoV-2 is a newly emerging virus. The antibody response in infected patients remains largely unknown, and the clinical value of ant...

2020 Clinical Infectious Diseases 2652 citations

Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients

Nisreen M.A. Okba , Marcel A. Müller , Wentao Li +16 more

A new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently emerged to cause a human pandemic. Although molecular diagnostic tests were rapidly...

2020 Emerging infectious diseases 1653 citations

Relationship between Anti-Spike Protein Antibody Titers and SARS-CoV-2<i>In Vitro</i>Virus Neutralization in Convalescent Plasma

Eric Salazar , Suresh V. Kuchipudi , Paul A. Christensen +31 more

Abstract Newly emerged pathogens such as SARS-CoV-2 highlight the urgent need for assays that detect levels of neutralizing antibodies that may be protective. We studied the rel...

2020 bioRxiv (Cold Spring Harbor Laboratory) 70 citations

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

Luca Piccoli , Young‐Jun Park , M. Alejandra Tortorici +47 more

Analysis of the specificity and kinetics of neutralizing antibodies (nAbs) elicited by SARS-CoV-2 infection is crucial for understanding immune protection and identifying target...

2020 Cell 1563 citations

IgA dominates the early neutralizing antibody response to SARS-CoV-2

Delphine Sterlin , Alexis Mathian , Makoto Miyara +24 more

Early specific antibody responses against SARS-CoV-2 include IgG, IgM, and IgA, but IgA may neutralize virus and control infection to a larger extent.

2020 Science Translational Medicine 1089 citations

Publication Info

Year: 2020
Type: article
Volume: 396
Issue: 10247
Pages: 313-319
Citations: 1125
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1125

OpenAlex

Cite This

APA Style

                            
                                
                                    Silvia Stringhini, 
                                
                                    Ania Wisniak, 
                                
                                    Giovanni Piumatti
                                
                                et al.
                            
                            (2020). 
                            Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. 
                            The Lancet
                            , 396
                            (10247)
                            , 313-319.
                            https://doi.org/10.1016/s0140-6736(20)31304-0
                        

Identifiers

DOI: 10.1016/s0140-6736(20)31304-0